Your browser doesn't support javascript.
loading
Analysis of the Prophylactic use of Hydroxychloroquine at the Beginning of the COVID-19 Pandemic Among Physicians.
Gönenli, Mehmet Gökhan; Kayi, Ilker; Alpay-Kanitez, Nilüfer; Baydas, Tuba; Köse, Murat; Nalbantoglu, Emine Ayça; Keskinler, Miraç Vural; Akpinar, Timur Selçuk; Ergönül, Önder.
Afiliación
  • Gönenli MG; Department of Internal Medicine, Koç University Hospital, Istanbul, Turkey.
  • Kayi I; Department of Public Health, Koç University Hospital, Istanbul, Turkey.
  • Alpay-Kanitez N; Department of Internal Medicine, Koç University Hospital, Istanbul, Turkey.
  • Baydas T; Department of Internal Medicine, Bezmialem University Hospital, Istanbul, Turkey.
  • Köse M; Department of Internal Medicine, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.
  • Nalbantoglu EA; Department of Internal Medicine, Koç University Hospital, Istanbul, Turkey.
  • Keskinler MV; Department of Internal Medicine, Istanbul Medeniyet University, Göztepe Education and Research Hospital, Istanbul, Turkey.
  • Akpinar TS; Department of Internal Medicine, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.
  • Ergönül Ö; Department of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Turkey.
Infect Dis Clin Microbiol ; 4(4): 236-243, 2022 Dec.
Article en En | MEDLINE | ID: mdl-38633712
ABSTRACT

Objective:

Throughout the pandemic, physicians working at the frontlines have embarked on various quests to protect themselves, and many physicians preferred using hydroxychloroquine (HQN) as a prophylactic agent. This study aimed to investigate the reasons leading physicians to use HQN and its effects on them. Materials and

Methods:

This study is cross-sectional with a target population of physicians working in pandemic hospitals in Istanbul, Turkey. We invited participants from seven hospitals via email between May 14 and June 13, 2020. An online questionnaire, including 57 questions, was sent to physicians.

Results:

A total of 148 (26%) physicians out of 564 participants had used hydroxychloroquine for prevention. Older physicians and those with a history of exposure to COVID-19 patients without protection used prophylactic HQN more frequently. The use of HQN did not differ statistically in terms of being infected among the exposed physicians (p=0.52). Nineteen (13%) physicians using HQN developed side effects related to the drug. Diarrhea and nausea were the most common.

Conclusion:

Prophylactic HQN use was more common among physicians older than 40 years and with higher exposure rates to a COVID-19 patient without protection. The physicians working on the front line had the highest rate of infection. HQN was not effective in the prophylaxis of COVID-19 among the exposed physicians.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Clin Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Clin Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Turquía